Literature DB >> 35945341

Consensus statement for metastatic surveillance of uveal melanoma in Scotland.

Vikas Chadha1, Paul Cauchi2, Wilma Kincaid3, Ashita Waterston4, Stefano Schipani4, Sachin Salvi5, Oliver Cram3, Diana Ritchie4.   

Abstract

Ophthalmic treatments are successful in managing uveal melanomas achieving good local control. However, a large number still metastasise, primarily to the liver, resulting in mortality. There is no consensus across the world on the mode, frequency, duration or utility of regular liver surveillance for metastasis and there are no published protocols. The Scottish Ocular Oncology Service (SOOS) constituted a Scottish Consensus Statement Group (SCSG) which included ocular oncologists, medical oncologists, radiologists and a uveal melanoma patient as a lay member. This group carried out an extensive review of literature followed by discussions to arrive at a consensus regarding surveillance planning for posterior uveal melanoma patients in Scotland. The Consensus Statement would provide a framework to guide each patient's surveillance plan and provide all patients with clarity and transparency on the issue. The SCSG was unable to find adequate evidence on which to base the strategy. The consensus statement recommends a risk-stratified approach to surveillance for these patients dividing them into low to medium-risk and high-risk groups defining the mode and duration of surveillance for each. It supplements the UK-wide Uveal Melanoma National Guidelines and allows a more uniform consensus-based approach to surveillance in Scotland. It has been adopted nationally by all health care providers in Scotland as a guideline and is available to patients on a publicly accessible website.
© 2022. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Entities:  

Year:  2022        PMID: 35945341     DOI: 10.1038/s41433-022-02198-w

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   4.456


  36 in total

Review 1.  Uveal Melanoma UK National Guidelines.

Authors:  P Nathan; V Cohen; S Coupland; K Curtis; B Damato; J Evans; S Fenwick; L Kirkpatrick; O Li; E Marshall; K McGuirk; C Ottensmeier; N Pearce; S Salvi; B Stedman; P Szlosarek; N Turnbull
Journal:  Eur J Cancer       Date:  2015-08-13       Impact factor: 9.162

2.  Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26.

Authors:  Marie Diener-West; Sandra M Reynolds; Donna J Agugliaro; Robert Caldwell; Kristi Cumming; John D Earle; Barbara S Hawkins; James A Hayman; Ishmael Jaiyesimi; Lee M Jampol; John M Kirkwood; Wui-Jin Koh; Dennis M Robertson; John M Shaw; Bradley R Straatsma; Jonni Thoma
Journal:  Arch Ophthalmol       Date:  2005-12

3.  Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study.

Authors:  L Khoja; E G Atenafu; S Suciu; S Leyvraz; T Sato; E Marshall; U Keilholz; L Zimmer; S P Patel; S Piperno-Neumann; J Piulats; T T Kivelä; C Pfoehler; S Bhatia; P Huppert; L B J Van Iersel; I J M De Vries; N Penel; T Vogl; T Cheng; G Fiorentini; F Mouriaux; A Tarhini; P M Patel; R Carvajal; A M Joshua
Journal:  Ann Oncol       Date:  2019-08-01       Impact factor: 32.976

4.  Variates of survival in metastatic uveal melanoma.

Authors:  Petra Rietschel; Katherine S Panageas; Christine Hanlon; Ami Patel; David H Abramson; Paul B Chapman
Journal:  J Clin Oncol       Date:  2005-11-01       Impact factor: 44.544

Review 5.  Uveal melanoma: trends in incidence, treatment, and survival.

Authors:  Arun D Singh; Mary E Turell; Allan K Topham
Journal:  Ophthalmology       Date:  2011-06-24       Impact factor: 12.079

6.  Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes.

Authors:  Carol L Shields; Minoru Furuta; Archana Thangappan; Saya Nagori; Arman Mashayekhi; David R Lally; Cecilia C Kelly; Danielle S Rudich; Anand V Nagori; Oojwala A Wakade; Sonul Mehta; Lauren Forte; Andrew Long; Elaina F Dellacava; Bonnie Kaplan; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2009-08

Review 7.  Treatment of primary intraocular melanoma.

Authors:  Bertil Damato
Journal:  Expert Rev Anticancer Ther       Date:  2006-04       Impact factor: 4.512

8.  Survival in patients with uveal melanoma in Europe.

Authors:  Gianni Virgili; Gemma Gatta; Laura Ciccolallo; Riccardo Capocaccia; Annibale Biggeri; Emanuele Crocetti; Jean-Michel Lutz; Eugenio Paci
Journal:  Arch Ophthalmol       Date:  2008-10

9.  Effectiveness of treatments for metastatic uveal melanoma.

Authors:  James J Augsburger; Zélia M Corrêa; Adeel H Shaikh
Journal:  Am J Ophthalmol       Date:  2009-04-17       Impact factor: 5.258

10.  Staging of ciliary body and choroidal melanomas based on anatomic extent.

Authors:  Emma Kujala; Bertil Damato; Sarah E Coupland; Laurence Desjardins; Nikolaos E Bechrakis; Jean-Daniel Grange; Tero Kivelä
Journal:  J Clin Oncol       Date:  2013-07-01       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.